News

News

分类出来

Our company became a founding member unit of Nanjing Biomedical Technology Industry Innovation Investment Promotion Association

  • Categories:Company news
  • Author:
  • Origin:
  • Time of issue:2019-12-30
  • Views:3

(Summary description)On December 29, led by the Nanjing Investment Promotion Bureau, with the participation of more than 300 people in the fields of "political, industrial

Our company became a founding member unit of Nanjing Biomedical Technology Industry Innovation Investment Promotion Association

(Summary description)On December 29, led by the Nanjing Investment Promotion Bureau, with the participation of more than 300 people in the fields of "political, industrial

  • Categories:Company news
  • Author:
  • Origin:
  • Time of issue:2019-12-30
  • Views:3
Information
On December 29, led by the Nanjing Investment Promotion Bureau, with the participation of more than 300 people in the fields of "political, industrial, academic, research, medical, and funding", the Nanjing Biomedical Industry Innovation Investment Promotion Association (hereinafter referred to as "Pharmaceutical Promotion ") The first council was convened, and the" Medicine Promotion Association "leadership team was elected. This is the city's first investment promotion association in the landmark industry field, and it is also an attempt by Nanjing to fully integrate various elements of the biomedical industry by attracting business and industrial ecology.
缘 Why does Nanjing rush to set up a "Medicine Promotion Association" at the end of 2019? To this end, the person in charge of Nanjing Investment Promotion Bureau gave the answer at the scene, "To comprehensively promote the high-quality development of Nanjing, in accordance with the decision-making and deployment of the municipal party committee and municipal government to build a '4 + 4 + 1' leading industrial system, Nanjing is As a new engine for high-quality economic development, the biopharmaceutical industry gathers industrial resources and innovation factors, builds a 100 billion-level industrial cluster, builds the province's first, top three, and globally influential industrial landmarks, and makes Nanjing a world-renowned Biomedical innovation center, unique gene technology and cell therapy industry highland.
As one of the cities with the largest number of biomedical education colleges in China, Nanjing has the leading position in biomedical talents nationwide. But at the same time, the development of the biomedical industry also has the problems of small total industrial scale and low capital activity. In order to effectively promote the high-quality development of the city's biopharmaceutical industry, the Nanjing Investment Promotion Bureau has promoted the establishment of the Nanjing Biopharmaceutical Industry Innovation and Investment Promotion Association. At the founding meeting of the day, the chairman of Jiangsu Xiansheng Pharmaceutical Co., Ltd. The first rotating chairman of the Promotion Committee. Shen Hongbing, Wang Xuehao, Fan Daiming, Wang Guangji and other domestic academician-level experts have also been hired as consultants of the "Promotion Association." Investment Promotion Association for the gathering and development of innovation elements in a single industry chain.
Our company became a founding member unit of Nanjing Biomedical Technology Industry Innovation Investment Promotion Association.

Scan the QR code to read on your phone

这是描述信息

Nanjing Purite Biotechnology Co., Ltd. 

Location: 3rd Floor, Building 6, 123 Houjiao Road, Jiangning District, Nanjing, China

Telephone:+86-025-52715975
           17749585716

E-mail:sales@predicte.cn

Contact: Mr. Liu Zhibin

这是描述信息

Copyright  2019  Nanjing Purite Biotechnology Co., Ltd.    www.300.cn    苏ICP备15006463号-1